 nonlymphoblast lymphoma children histolog stage-rel respons therapi pediatr oncolog group studi from may march elig patient nonlymphoblast lymphoma nlbl member pediatr oncolog group pog adriamycin doxorubicin adria columbu OH vincristin prednison cyclophosphamid mercaptopurin acop+ cn prophylaxi intrathec IT methotrex hydrocortison cranial irradi rad radiat therapi primari diseas stage II diseas stage iii IV durat treatment year stage II iii year stage IV diseas patient studi small noncleaved-cel lymphoma dsncl large-cel lymphoma dlcl histolog diseas II present patient stage iii IV diseas studi import stage event-fre surviv ef SE patient local diseas SE patient advanc diseas equal local diseas advers event patient therapi month initi diagnosi relaps second malign death remiss large-cel histolog import prognost factor patient stage iii IV diseas ef year SE dlcl SE dsncl equal import small noncleaved-cel large-cel type nlbl basi clinic trial